Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05120518

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).

Detailed description

The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG). This model system will then be subjected to 1) comprehensive histopathological and molecular characterizations during serial in vivo sub-transplantations; 2) cryopreserved for long term preservation of tumorigenicity; and 3) used for future biological studies and preclinical drug testing.

Conditions

Interventions

TypeNameDescription
OTHERCollection of post mortem tissue donationCollection of post mortem tissue from pediatric participants with cancer and non-cancer tumor types from whom post mortem tissue donation and autopsy consent is obtained.

Timeline

Start date
2019-08-14
Primary completion
2029-08-14
Completion
2029-08-14
First posted
2021-11-15
Last updated
2024-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05120518. Inclusion in this directory is not an endorsement.